An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

Patients with deadly skin cancer could soon benefit from a revolutionary vaccine that has been shown to slash the risk of their disease returning by almost half.

An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year